Clinical Manifestations and Outcomes of Pulmonary Aspergillosis: Experience from Pakistan

Overview

Journal BMJ Open Respir Res

Date 2017 Jan 12

PMID 28074136

Citations 20

Authors

Nousheen Iqbal

Muhammad Irfan

Ali Bin Sarwar Zubairi

Kauser Jabeen

Safia Awan

Javaid A Khan

Affiliations

Soon will be listed here.

Abstract

Introduction: Pulmonary aspergillosis has variable course of illness, severity and outcomes depending on underlying conditions. There is limited data available on the clinical manifestations and outcome of pulmonary aspergillosis from Pakistan.

Methods: To determine the clinical manifestations and outcome of pulmonary aspergillosis in a tertiary care hospital a retrospective study was conducted from 2004 to 2014 in patients admitted with pulmonary aspergillosis at the Aga Khan University Hospital Karachi, Pakistan.

Results: Of the 280 cases with provisional diagnosis of aspergillosis 69 met the inclusion criteria. The mean age was 45±15.7 years, 48 (69.6%) were men and 21 (30.4%) had diabetes mellitus (DM). The average length of hospital stay (LOS) was 10.61±9.08 days. was the most common (42.0%), followed by (28.9%). More than one-third of patients previously had tuberculosis (TB) (39.13%). The commonest pulmonary manifestation was chronic pulmonary aspergillosis (CPA) 47 (68.1%) followed by invasive pulmonary aspergillosis (IPA) 12 (17.4%) and subacute invasive aspergillosis (SAIA) 8 (11.6%). Surgical excision was performed in 28 patients (40.57%). Intensive care unit admission was required for 18 patients (26.08%). Case fatality rate was 14/69 (20.3%). DM, mean LOS and hypoxic respiratory failure were identified as independent risk factors of mortality on multivariate analysis.

Conclusion: was the most frequent species found especially in patients with prior TB. CPA was the commonest pulmonary manifestation seen as post TB sequel. Diabetes, hypoxic respiratory failure and increased LOS were independent predictors of poor outcomes. Overall patients had good outcome with CPA compared with SAIA and IPA.

Citing Articles

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria.

Balogun O, Oladele R, Ajibola O, Davies A, Fashanu T, Nwosu A Microbiol Spectr. 2025; 13(3):e0153324.

PMID: 39912682 PMC: 11878091. DOI: 10.1128/spectrum.01533-24.

Prognostic factors and outcomes of invasive pulmonary aspergillosis, a retrospective hospital-based study.

Chen W, Chen I, Chen J, Liao T, Chen Y PeerJ. 2024; 12:e17066.

PMID: 38436032 PMC: 10908254. DOI: 10.7717/peerj.17066.

Prevalence of chronic pulmonary aspergillosis in fibrocavitary pulmonary tuberculosis patients.

Rajpurohit R, Wagh P, Heda M, Dubey G, Gujar P J Family Med Prim Care. 2023; 12(1):106-110.

PMID: 37025238 PMC: 10071912. DOI: 10.4103/jfmpc.jfmpc_846_22.

Sensitivity of Antigen, Serology, and Microbiology Assays for Diagnosis of the Subtypes of Chronic Pulmonary Aspergillosis at a Teaching Hospital in São Paulo, Brazil.

de Oliveira V, Viana J, Sawamura M, Magri A, Costa A, Abdala E Am J Trop Med Hyg. 2022; 108(1):22-26.

PMID: 36450228 PMC: 9833085. DOI: 10.4269/ajtmh.22-0412.

Molecular Characterization and Antifungal Susceptibility of spp. among Patients with Underlying Lung Diseases.

Moglad E, Saeed S, Saeed H, Ahmed H, Salih K, Altayb H Trop Med Infect Dis. 2022; 7(10).

PMID: 36288015 PMC: 9612272. DOI: 10.3390/tropicalmed7100274.

References

Janes S, Barker K, Mak V, Bell D . Invasive pulmonary aspergillosis in an insulin-dependent diabetic. Respir Med. 1999; 92(7):972-5. DOI: 10.1016/s0954-6111(98)90201-3. View

De Pauw B, Walsh T, Donnelly J, Stevens D, Edwards J, Calandra T . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group.... Clin Infect Dis. 2008; 46(12):1813-21. PMC: 2671227. DOI: 10.1086/588660. View

Walsh T, Anaissie E, Denning D, Herbrecht R, Kontoyiannis D, Marr K . Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(3):327-60. DOI: 10.1086/525258. View

Takuma T, Okada K, Uchida Y, Yamagata A, Sawae Y . Invasive pulmonary aspergillosis resulting in respiratory failure during neutrophil recovery from postchemotherapy neutropenia in three patients with acute leukaemia. J Intern Med. 2002; 252(2):173-7. DOI: 10.1046/j.1365-2796.2002.01012.x. View

Rosenberg M, Patterson R, Mintzer R, COOPER B, Roberts M, Harris K . Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med. 1977; 86(4):405-14. DOI: 10.7326/0003-4819-86-4-405. View

Dooley K, Chaisson R . Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9(12):737-46. PMC: 2945809. DOI: 10.1016/S1473-3099(09)70282-8. View

Greene R . The radiological spectrum of pulmonary aspergillosis. Med Mycol. 2005; 43 Suppl 1:S147-54. DOI: 10.1080/13693780500064771. View

Denning D . Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect. 2001; 7 Suppl 2:25-31. DOI: 10.1111/j.1469-0691.2001.tb00006.x. View

Singh U, Aneja P, Aditi , Patel K . Co-existence of HIV, active tuberculosis and aspergilloma in a single individual--a case report. Indian J Tuberc. 2013; 60(1):55-8. View

10.

Baker M, Harries A, Jeon C, Hart J, Kapur A, Lonnroth K . The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011; 9:81. PMC: 3155828. DOI: 10.1186/1741-7015-9-81. View

11.

Smith N, Denning D . Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur Respir J. 2010; 37(4):865-72. DOI: 10.1183/09031936.00054810. View

12.

Ahmad T, Ahmed S, Hussain N, Rais K . Clinical profile and postoperative outcome in patients with simple and complex aspergilloma of lung. J Coll Physicians Surg Pak. 2010; 20(3):190-3. DOI: 03.2010/JCPSP.190193. View

13.

Kousha M, Tadi R, Soubani A . Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011; 20(121):156-74. PMC: 9584108. DOI: 10.1183/09059180.00001011. View

14.

Patterson T, Kirkpatrick W, White M, Hiemenz J, Wingard J, DuPont B . Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore). 2000; 79(4):250-60. DOI: 10.1097/00005792-200007000-00006. View

15.

Roberts C, Empey D . Chronic necrotizing pulmonary aspergillosis and pulmonary phycomycosis in cystic fibrosis. Respir Med. 1994; 88(6):465-8. DOI: 10.1016/s0954-6111(05)80051-4. View

16.

Gaeta M, Blandino A, Scribano E, Minutoli F, VOLTA S, Pandolfo I . Computed tomography halo sign in pulmonary nodules: frequency and diagnostic value. J Thorac Imaging. 1999; 14(2):109-13. DOI: 10.1097/00005382-199904000-00008. View

17.

Heussel C, Kauczor H, Heussel G, Fischer B, Begrich M, Mildenberger P . Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol. 1999; 17(3):796-805. DOI: 10.1200/JCO.1999.17.3.796. View

18.

Lee H, Kim Y, Cho J, Lee C . Empyema necessitatis due to Aspergillus fumigatus. BMJ Case Rep. 2014; 2014. PMC: 4256667. DOI: 10.1136/bcr-2014-206047. View

19.

Binder R, Faling L, Pugatch R, Mahasaen C, Snider G . Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore). 1982; 61(2):109-24. DOI: 10.1097/00005792-198203000-00005. View

20.

Jimenez-Corona M, Cruz-Hervert L, Garcia-Garcia L, Ferreyra-Reyes L, Delgado-Sanchez G, Bobadilla-Del-Valle M . Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2012; 68(3):214-20. PMC: 3585483. DOI: 10.1136/thoraxjnl-2012-201756. View